Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced the appointment of Gary Palmer, M.D., J.D., M.B.A., M.P.H. to the newly created position of senior vice president, medical affairs and commercial development. In this role, Dr. Palmer will drive …
Read more on Business Wire
Categories: Breast Cancer Information Tags: Affairs, Appoints, Commercial, Development, Foundation, Gary, M.D., Medical, medicine, Palmer, President, Senior, Vice
ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication
ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication
ZIOPHARM Oncology, Inc. announced today that it has appointed Michael G. King, Jr., Senior Vice President of Corporate Development and Communication. In this newly established position, Mr.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: Appoints, communication, Corporate, Development, king, Michael, Oncology, President, Senior, Vice, ZIOPHARM
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
CAMBRIDGE, Mass.—-AVEO Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the appointment of Michael P.
Read more on Business Wire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Appoints, AVEO, Bailey, chief, Commercial, Created, Inc., Michael, newly, officer, Pharmaceuticals, position
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance